The Defense Logistics Agency (DLA) awarded a $2,704.00 firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of MULTIHANCE 529 MG/ML VIAL 10ML. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, to provide a comprehensive range of pharmaceutical products and medical supplies in support of military treatment...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $1,019 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply 15ml vials of the contrast agent Multihance 529 mg/ml. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by December 14, 2023. No set-aside designation was applied to this award made against an indefinite-delivery contract held by...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $1,513.68 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of MULTIHANCE 529 MG/ML VIAL 20ML, a pharmaceutical product. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp as the prime contractor. The IDC allows Amerisourcebergen to deliver a...
<p>The Defense Logistics Agency awarded a $528.65 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561621938 OMNIPAQUE 300 MG/ML VIAL 10ML. The prime contractor will deliver the contrast agent to a facility located in Conshohocken, Pennsylvania by July 28, 2023 under the terms of the order. No additional details were provided regarding the original solicitation or whether this award was issued against an existing government-wide acquisition contract vehicle.</p>
The Defense Logistics Agency awarded a $417,000 delivery order to Amerisourcebergen Drug Corporation for 4561418705 VISIPAQUE 320 MG/ML INFUS BTL 150ML. The firm fixed price order is for the delivery of this contrast agent to a facility located in Conshohocken, Pennsylvania. Performance will take place between July 6-7, 2023. No additional details were provided regarding the original solicitation, any associated contracts or vehicles, subcontractors, or high-level Defense Department programs.
This contract award is for the provision of Gadavist 1 mmol/ml bulk vials (30ml) to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract, valued at $1,711.35, is a delivery order under a larger Indefinite Delivery Contract (IDC) with Amerisourcebergen Drug Corp, the prime contractor. Amerisourcebergen, a major pharmaceutical distribution company, is the sole awardee on this IDC valued at up to $999,999,999.00 to supply a range of pharmaceutical products...
The Defense Logistics Agency awarded a $526.60 delivery order to Amerisourcebergen Drug Corporation for 4561807701 OMNIPAQUE 180 MG/ML VIAL 10ML. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle and calls for delivery of the contrast agent to a facility in Conshohocken, Pennsylvania by August 15, 2023. As the DLA supports medical readiness for the U.S. Department of Defense, this contract will likely provide imaging materials to a military...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. (doing business as AmerisourceBergen). The $1,621.40 award is for the delivery of Gadavist, a 7.5 mL contrast agent vial, to support military treatment programs and facilities.
The award is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with DLA, valued at up to...
The Defense Logistics Agency awarded a $7,006.55 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562007332 OMNIPAQUE 300 MG/ML VIAL 10ML. As the prime contractor, Amerisourcebergen will deliver this contrast agent to locations within Conshohocken, Pennsylvania by September 1, 2023 in support of the Defense Logistics Agency's medical supply chain requirements. No subcontractors or set aside designations were identified for this delivery order placed under an existing...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $8,258.75 contract is for the supply of Gadavist, a 10 mL vial of contrast agent used in medical imaging procedures. The delivery order is part of a larger indefinite delivery contract (IDC) with a potential value up to $999,999,999.00, which serves as the primary...